C-cell hyperplasia;Hyperplasies des cellules C

Annales d'Endocrinologie

Volumn 67, Issue 3, 2006, Pages 190-197

  Guyetant S ^a,b   Blechet C ^a,c   Saint Andre J P ^d  

^a UNIVERSITÉ DE TOURS   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c CHU BRETONNEAU   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

C cell; Hyperplasia; MEN II; RET; Thyroid

Indexed keywords

PROTEIN RET;

C CELL; CELL; CELL DENSITY; CELL HYPERPLASIA; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOCRINE TUMOR; GENE MUTATION; GOITER; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; THYROID DISEASE; THYROID HYPERPLASIA; THYROIDECTOMY; THYROIDITIS;

EID: 33745656630     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(06)72585-9     Document Type: Article

References (51)

1. Albores-Saavedra JA, Krueger JE. C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol 2001 ; 2 : 365-77.
2. Albores-Saavedra J, Monforte H, Nadji M et al. C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 1988 ; 19 : 795-9.
3. Barbot N, Guyétant S, Beldent V et al. Thyroïdite chronique auto-immune et hyperplasie des cellules C. Étude de la sécrétion de calcitonine chez 24 patients. Ann Endocrinol 1991 ; 52 : 109-21.
4. Beckner ME, Shultz JJ, Richardson T. Solid and cystic ultimobranchial body remnants in the thyroid. Arch Pathol Lab Med 1990 ; 114 : 1049-52.
5. Biddinger PW, Brennan MF, Rosen PP. Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. Am J Surg Pathol 1991 ; 15 : 599-604.
6. De Lellis RA, Nunnemacher G, Wolfe JH. C-cell hyperplasia. An ultrastructural analysis. Lab Invest 1977 ; 36 : 237-48.
7. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Wolfe HJ. Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia. J Clin Endocrinol Metab 2001 ; 86 : 3948-57.
8. Elisei R, Bottici V, Luchetti F et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10.864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004 ; 89 : 163-8.
9. Franc B, Modigliani E. Le carcinome médullaire de la thyroïde : évolution des concepts. Arch Anat Cytol Path 1998 ; 46 : 100-11.
10. Franc B, Akrwight A, Caillou B et al. Expressions morphologiques des carcinomes médullaires de la thyroïde (CMT) dans les formes familiales. In: Medullary Thyroid Carcinoma/Ed. Calmettes C, Guliana JM. Paris : Colloque INSERM/John Libbey Eurotext Ltd, 1991. vol. 211, pp. 159-61.
11. Garcia-Ameijeiras A, De La Torre W, Rodriguez-Espinosa J et al. Does testosterone influence the post-stimulatory levels of calcitonin in normal men? Clin Endocrinol 1987 ; 27 : 545-52.
12. Gibelin H, Essique D, Jones C, Levillain P, Marechaud R, Kraimps JL. Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 2005 ; 92 : 574-8.
13. Greenberg C, Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams GA. Effects of estradiol and progesterone on calcitonin secretion. Endocrinology 1986 ; 118 : 2594-8.
14. Guyétant S, Josselin N, Savagner F, Rohmer V, Michalak S, Saint-André JP. C-cell hyperplasia and medullary thyroid carcinoma. Clinico-pathological, biological and genetic correlations in a series of 66 consecutive patients. Mod Pathol 2003 ; 16 : 756-63.
15. Guyétant S, Saint-André JP. Hyperplasie des cellules C et microcarcinomes médullaires de la thyroïde. Ann Pathol 2000 ; 20 : S39-S44.
16. Guyétant S, Wion-Barbot N, Rousselet MC, Franc B, Bigorgne J-C, Saint-André JP. C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. Hum Pathol 1994 ; 25 : 514-21.
17. Guyétant S, Rousselet M-C, Durigon M et al. Sex-related C-cell hyperplasia in the normal human thyroid. A quantitative autopsy study. J Clin Endocrinol Metab 1997 ; 82 : 42-7.
18. Harach R. Solid cell nests of the thyroid. J Pathol 1988 ; 155 : 191-200.
19. Hinze R, Holzhausen H-J, Gimm O. Primary hereditary medullary thyroid carcinoma. C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch 1998 ; 433 : 203-8.
20. Hinze R, Gimm O, Brauckhoff M, Schneyer U, Dralle H, Holzhausen HJ. "Physiologische" und "neoplastische" C-Zell-Hyperplasien der Schilddrüse. Morphologisch und biologisch distinkte Entitäten? Pathologe 2001 ; 22 : 259-65.
21. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 2002 ; 26 : 886-90.
22. Karanikas G, Moameni A, Poetzi C et al. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 2004 ; 89 : 515-9.
23. Kaserer K, Scheuba C, Neuhold N et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 1998 ; 22 : 722-8.
24. Kaserer K, Scheuba C, Neuhold N et al. Sporadic versus familial medullary thyroid microcarcinoma : a histopathologic study of 50 consecutive patients. Am J Surg Pathol 2001 ; 25 : 1245-51.
25. Krueger J, Maitra A, Albores-Saavedra J. Inherited medullary microcarcinoma of the thyroid. A study of 11 cases. Am J Surg Pathol 2000 ; 24 : 853-8.
26. Le Douarin N, Le Lièvre C. Démonstration de l'origine neurale des cellules àcalcitonine du corps ultimo-branchial chez l'embryon de poulet. C. R. Acad. Sc. Paris. 1970, t.270, série D, 2857-60.
27. Libbey NP, Nowakowski KJ, Tucci JR. C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. Am J Surg Pathol 1989 ; 13 : 71-7.
28. Lima J, Teixeira-Gomes J, Soares P et al. Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. J Clin Endocrinol Metab 2003 ; 88 : 4932-7.
29. Lima MA, Santos BM, Borges MF. Quantitative analysis of C cells in Hashimoto's thyroiditis. Thyroid 1998 ; 8 : 505-9.
30. LiVolsi VA, Feind CR, LoGerfo P, Tashjian AH. Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism. J Clin Endocrinol Metab 1973 ; 37 : 550-9.
31. Ljungberg O, Dymling JF. Pathogenesis of C-cell neoplasia in the thyroid gland. C-cell proliferation in a case of chronic hypercalcaemia. Acta Pathol Microbiol Scand (A) 1972 ; 80 : 577-88.
32. Lukacs G, Sapy Z, Gyory F et al. Distribution of cacitonin-containing parafollicular cells of the thyroid in patients with chronic lymphocytic thyroiditis: a clinical, pathological and immunohistochemical study. Acta Chir Hung 1997 ; 36 : 204-6.
33. Machens A, Niccoli-Sire P, Hoegel J et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003 ; 349 : 1517-25.
34. Machens A, Holzhausen HJ, Thanh PN, Dralle H. Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 2003 ; 134 : 425-31.
35. Martin V, Martin L, Viennet G, Challier B, Carbillet J, Fellmann D. «Solid Cell Nests» et pathologies thyroïdiennes. Étude rétrospective de 1390 thyroïdes. Ann Pathol 2000 ; 20 ; 196-201.
36. Niccoli P, Wion-Barbot N, Caron P et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 1997 ; 82 : 338-41.
37. Niccoli-Sire P, Murat A, Rohmer V et al. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients. J Clin Endocrinol Metab 2001 ; 86 : 3746-53.
38. Niccoli P, Conte-Devolx B, Lejeune PJ et al. Les hypercalcitoniné mies en dehors des cancers médullaires de la thyroïde. Ann Endocrinol 1996 ; 57 : 15-21.
39. Pacini F, Fontanelli M, Fugazzola L et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary carcinoma. J Clin Endocrinol Metab 1994 ; 78 : 826-9.
40. Pantazi H, Papapetrou PD. Calcitonin levels are similar in goitrous euthyroid patients with or without thyroid antibodies, as well as in hypothyroid patients. Eur J Endocrinol 1998 ; 138 : 530-5.
41. Perry A, Molberg K, Albores-Saavedra J. Physiologic versus neoplastic C cell hyperplasia of the thyroid. Separation of distinct histologic and biologic entities. Cancer 1996 ; 77 : 750-6.
42. Santeusanio G, Iafrate E, Partenzi A et al. A critical reassessment of the concept of C cell hyperplasia of the thyroid. A quantitative immunohistochemical study. Appl Immunohistochem 1997 ; 5 : 160-72.
43. Scheuba C, Kaserer K, Kotzmann H, Bieglmayer C, Niederle B, Vierhapper H. Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin. Thyroid 2000 ; 10 : 413-6.
44. Scopsi L, Di Palma S, Ferrari C, Holst JJ, Rehfeld JF, Rilke F. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin. Mod Pathol 1991 ; 4 : 297-304.
45. Tomita T, Millard DM. C-cell hyperplasia in secondary hyperparathyroidism. Histopathology 1992 ; 21 : 469-74.
46. Van Lathem JJM, Vermaak WJH, Kuyl JM et al. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members. J Clin Lab Anal 1992 ; 6 : 384-90.
47. Wolfe HJ, Melvin KE, Cervi-Skinner SJ et al. C-cell hyperplasia preceding medullary thyroid carcinoma. N Eng J Med 1973 ; 289 : 437-41.
48. Wolfe HJ, De Lellis RA, Scott RT et al. C-cell hyperplasia in chronic hypercalcemia in man (abstract). Am J Pathol 1975 ; 78 : 20A.
49. Yang K, Pearson CE, Samaan NA. Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continuous culture. Cancer Res 1988 ; 48 : 2760-3.
50. Zhai QH, Ruebel K, Thompson GB, Lloyd RV. Androgen receptor expression in C-cells and in medullary thyroid carcinoma. Endocr Pathol 2003 ; 14 : 159-65.
51. Zink A, Blind E, Raue F. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma. Eur J Clin Chem Clin Biochem 1992 ; 30 : 831-5.